Cambrian Bio

Cambrian Biopharma is a biotechnology research and development firm focused on the biology of aging, also known as geroscience. The company aims to develop therapeutics that address the molecular damage associated with aging and related chronic diseases. By employing a "Distributed R&D Company" model, Cambrian partners with leading academic geroscientists to create new companies, conduct preclinical drug discovery, and manage clinical trials. This collaborative approach allows Cambrian to efficiently translate scientific discoveries into clinical applications, aiming to improve quality of life through proactive interventions. The company has successfully launched ten companies in partnership with prominent geroscientists and maintains relationships with over 100 geroscience-focused laboratories worldwide, facilitating rapid development and deployment of age-related disease therapies.